CLINICAL_TRIALS trial_result · 2012-10-31

Clinical Trial Update: Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes [Phase 2]

Phase 2 trial update of an anti-CD3 monoclonal antibody in recent-onset type 1 diabetes (completed; results posted 2012-10-31).

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Yale University | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2012-10-31